N-(5-chloro-2-propoxybenzyl)-N-(4-(N-methyl-N-(prop-2-yn-1-yl)sulfamoyl)phenethyl)-2-(thiophen-3-yl)acetamide

ID: ALA5175251

Chembl Id: CHEMBL5175251

PubChem CID: 168274908

Max Phase: Preclinical

Molecular Formula: C28H31ClN2O4S2

Molecular Weight: 559.15

Associated Items:

Names and Identifiers

Canonical SMILES:  C#CCN(C)S(=O)(=O)c1ccc(CCN(Cc2cc(Cl)ccc2OCCC)C(=O)Cc2ccsc2)cc1

Standard InChI:  InChI=1S/C28H31ClN2O4S2/c1-4-14-30(3)37(33,34)26-9-6-22(7-10-26)12-15-31(28(32)18-23-13-17-36-21-23)20-24-19-25(29)8-11-27(24)35-16-5-2/h1,6-11,13,17,19,21H,5,12,14-16,18,20H2,2-3H3

Standard InChI Key:  UTNFSSRVCLQXAQ-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5175251

    ---

Associated Targets(Human)

HEK293 (82097 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Nlrp3 NACHT, LRR and PYD domains-containing protein 3 (641 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
J774.A1 (2436 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Nlrc4 NLR family CARD domain-containing protein 4 (37 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Aim2 Interferon-inducible protein AIM2 (37 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 559.15Molecular Weight (Monoisotopic): 558.1414AlogP: 5.26#Rotatable Bonds: 13
Polar Surface Area: 66.92Molecular Species: NEUTRALHBA: 5HBD:
#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: CX LogP: 5.38CX LogD: 5.38
Aromatic Rings: 3Heavy Atoms: 37QED Weighted: 0.27Np Likeness Score: -2.08

References

1. Xu Y, Xu Y, Blevins H, Guo C, Biby S, Wang XY, Wang C, Zhang S..  (2022)  Development of sulfonamide-based NLRP3 inhibitors: Further modifications and optimization through structure-activity relationship studies.,  238  [PMID:35635948] [10.1016/j.ejmech.2022.114468]

Source